Press releases
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
28 Mar 24
M&A, News, Press Releases
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
27 Mar 24
Press Releases
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12 Mar 24
Press Releases
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
15 Feb 24
Press Releases